MOLNUPIRAVIR

MOVFOR

Prescription Drug

Formulation

Where to buy

Mercury Drug; Watson; SouthStar Drug; Rose Pharmacy

Molnupiravir

Dosage

Initiate therapy as soon as possible following diagnosis of COVID-19 and within 5 days of symptom onset. Safety and efficacy of therapy beyond 5 consecutive days have not been established.

Indication

For the treatment of mild to moderate cases in nonhospitalised patients with confirmed positive SARS-CoV-2 diagnostic test result who have at least 1 risk factor for developing severe COVID-19, and in whom alternative COVID-19 treatment options approved or authorised by the US FDA are inaccessible or not clinically appropriate: 800 mg 12 hourly for 5 days.

Packaging:

Download Product Information